Lessons Learned from the European Cardiovascular Magnetic Resonance (EuroCMR) Registry Pilot Phase

被引：7
作者：
Bruder O. [1 ]
Wagner A. [2 ]
Mahrholdt H. [3 ]
机构：
[1] Department of Cardiology and Angiology, Elisabeth Hospital, 45138 Essen
[2] Hahnemann University Hospital, Drexel University College of Medicine, Philadelphia, PA
[3] Department of Cardiology, Robert Bosch Medical Centre, Stuttgart
来源：
Current Cardiovascular Imaging Reports | 2010年 / 3卷 / 3期
关键词：
Cardiovascular magnetic resonance; Effectiveness; Impact on patient management; Outcome; Quality; Registry; Safety;
D O I：
10.1007/s12410-010-9016-x
中图分类号：
学科分类号：
摘要：
The data from 11,040 patients of the European Cardiovascular Magnetic Resonance (EuroCMR) registry pilot phase offer the first documentation of the clinical use of CMR in a routine setting. The pilot data show that CMR is frequently performed in clinical practice, is a safe procedure with excellent image quality, and has a strong impact on patient management. In the future, the EuroCMR registry will help to set international benchmarks on appropriate indications, quality, and safety of CMR. In addition, outcome and cost effectiveness will be addressed on an international level in order to develop optimized imaging-guided clinical pathways and to avoid unnecessary or even harmful testing. © 2010 The Author(s).
引用
收藏
页码：171 / 174
页数：3
相关论文
共 23 条
  • [1] Einstein A.J., Henzlova M.J., Rajagopalan S., Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography, Jama, 298, pp. 317-323, (2007)
  • [2] Brenner D.J., Hall E.J., Computed tomography-an increasing source of radiation exposure, N Engl J Med, 357, pp. 2277-2284, (2007)
  • [3] Redberg R.F., Computed tomographic angiography: more than just a pretty picture?, J Am Coll Cardiol, 49, pp. 1827-1829, (2007)
  • [4] Shah B.R., Patel M.R., Peterson E.D., Et al., Defining optimal research study design for cardiovascular imaging using computed tomography angiography as a model, Am J Cardiol, 102, pp. 943-948, (2008)
  • [5] Klem I., Heitner J.F., Shah D.J., Et al., Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging, J Am Coll Cardiol, 47, pp. 1630-1638, (2006)
  • [6] Wagner A., Mahrholdt H., Holly T.A., Et al., Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study, Lancet, 361, pp. 374-379, (2003)
  • [7] Kim R.J., Wu E., Rafael A., Et al., The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction, N Engl J Med, 343, pp. 1445-1453, (2000)
  • [8] Mahrholdt H., Goedecke C., Wagner A., Et al., Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology, Circulation, 109, pp. 1250-1258, (2004)
  • [9] Nagel E., Lehmkuhl H.B., Bocksch W., Et al., Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography, Circulation, 99, pp. 763-770, (1999)
  • [10] Pennell D.J., Sechtem U.P., Higgins C.B., Et al., Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report, Eur Heart J, 25, pp. 1940-1965, (2004)
123